AJCN North Carolina Research Campus
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lovejoy, J. C
Right arrow Articles by Rood, J. C
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lovejoy, J. C
Right arrow Articles by Rood, J. C
Agricola
Right arrow Articles by Lovejoy, J. C
Right arrow Articles by Rood, J. C
American Journal of Clinical Nutrition, Vol. 76, No. 5, 1000-1006, November 2002
© 2002 American Society for Clinical Nutrition


Original Research Communication

Effect of diets enriched in almonds on insulin action and serum lipids in adults with normal glucose tolerance or type 2 diabetes1,2,3

Jennifer C Lovejoy, Marlene M Most, Michael Lefevre, Frank L Greenway and Jennifer C Rood

1 From the Pennington Biomedical Research Center, Louisiana State University, Baton Rouge.

Background: Nuts appear to have cardiovascular benefits but their effect in diabetic patients is unclear.

Objective: The objective was to assess effects of almond-enriched diets on insulin sensitivity and lipids in patients with normoglycemia or type 2 diabetes.

Design: Study 1 assessed the effect of almonds on insulin sensitivity in 20 free-living healthy volunteers who received 100 g almonds/d for 4 wk. Study 2 was a randomized crossover study that compared 4 diets in 30 volunteers with type 2 diabetes: 1) high-fat, high-almond (HFA; 37% total fat, 10% from almonds); 2) low-fat, high-almond (LFA; 25% total fat, 10% from almonds); 3) high-fat control (HFC; 37% total fat, 10% from olive or canola oil); and 4) low-fat control (LFC; 25% total fat, 10% from olive or canola oil). After each 4-wk diet, serum lipids and oral glucose tolerance were measured.

Results: In study 1, almond consumption did not change insulin sensitivity significantly, although body weight increased and total and LDL cholesterol decreased by 21% and 29%, respectively (P < 0.05). In study 2, total cholesterol was lowest with the HFA diet (4.46 ± 0.14, 4.52 ± 0.14, 4.63 ± 0.14, and 4.63 ± 0.14 mmol/L with the HFA, HFC, LFA, and LFC diets, respectively; P = 0.0004 for fat level). HDL cholesterol was significantly lower with the almond diets (P = 0.002); however, no significant effect of fat source on LDL:HDL was observed. Glycemia was unaffected.

Conclusions: Almond-enriched diets do not alter insulin sensitivity in healthy adults or glycemia in patients with diabetes. Almonds had beneficial effects on serum lipids in healthy adults and produced changes similar to high monounsaturated fat oils in diabetic patients.

Key Words: Nuts • almonds • insulin resistance • type 2 diabetes • lipoproteins • glucose tolerance




This article has been cited by other articles:


Home page
J. Nutr.Home page
R. D. Mattes, P. M. Kris-Etherton, and G. D. Foster
Impact of Peanuts and Tree Nuts on Body Weight and Healthy Weight Loss in Adults
J. Nutr., September 1, 2008; 138(9): 1741S - 1745S.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
P. M. Kris-Etherton, F. B. Hu, E. Ros, and J. Sabate
The Role of Tree Nuts and Peanuts in the Prevention of Coronary Heart Disease: Multiple Potential Mechanisms
J. Nutr., September 1, 2008; 138(9): 1746S - 1751S.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
D. J. A. Jenkins, F. B. Hu, L. C. Tapsell, A. R. Josse, and C. W. C. Kendall
Possible Benefit of Nuts in Type 2 Diabetes
J. Nutr., September 1, 2008; 138(9): 1752S - 1756S.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Coll. Nutr.Home page
M. J. Sheridan, J. N. Cooper, M. Erario, and C. E. Cheifetz
Pistachio Nut Consumption and Serum Lipid Levels
J. Am. Coll. Nutr., April 1, 2007; 26(2): 141 - 148.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
J. Mukuddem-Petersen, W. Oosthuizen, and J. C. Jerling
A Systematic Review of the Effects of Nuts on Blood Lipid Profiles in Humans
J. Nutr., September 1, 2005; 135(9): 2082 - 2089.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
A.-M. Paradis, B. Fontaine-Bisson, Y. Bosse, J. Robitaille, S. Lemieux, H. Jacques, B. Lamarche, A. Tchernof, P. Couture, and M.-C. Vohl
The peroxisome proliferator-activated receptor {alpha} Leu162Val polymorphism influences the metabolic response to a dietary intervention altering fatty acid proportions in healthy men
Am. J. Clinical Nutrition, February 1, 2005; 81(2): 523 - 530.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
M.-P. St-Onge
Dietary fats, teas, dairy, and nuts: potential functional foods for weight control?
Am. J. Clinical Nutrition, January 1, 2005; 81(1): 7 - 15.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2002 by The American Society for Nutrition